ERBB2 and breast cancer: In addition to the abovementioned tDR-0009 and tDR-7336 related to doxorubicin resistance [63], tRF-30-JZOYJE22RR33 and tRF-27-ZDXPHO53KSN were associated with trastuzumab resistance in HER-2-positive BC patients [42].